Introduction. Hysterectomy is a common gynecological procedure; however, the incidence of total and subtotal hysterectomy varies across countries, by age, and over time. As only women with an intact cervix are at risk of cervical cancer, failing to remove hysterectomized women from the denominator may underestimate the cervical cancer incidence. We aimed to describe the temporal and age-dependent patterns of cervical cancer incidence in Denmark before and after correction for hysterectomy. Material and methods. Using data from national registries we calculated uncorrected and hysterectomy-corrected cervical cancer incidence rates among women ≥20 years during 2000-11. Hysterectomycorrected rates were calculated by subtracting post-hysterectomy person-years from the denominator. Results. The overall uncorrected cervical cancer incidence rate was 17.8/100 000 person-years (95% CI 17.3-18.3). After correction for hysterectomy, the rate increased by 8.4% to 19.3/100 000 person-years (95% CI 18.8-19.9). The highest uncorrected incidence was seen in women aged 35-39 years, peaking at 24.4/100 000 person-years, whereas the highest hysterectomy-corrected cervical cancer incidence rate was observed in women aged 75-79 years (29.4/100 000 person-years). Over time, women ≥60 years had the highest hysterectomy-corrected cervical cancer incidence. Conclusions. Correcting for hysterectomy incidence resulted in a higher cervical cancer incidence and a shift in the peak incidence from age 35-39 years to age 75-79 years. Over time, women ≥60 years were at the highest risk of cervical cancer. Given the high incidence in women >60-65 years, when women are eligible to exit screening, a revision of the screening guidelines may be warranted.
Introduction
Hysterectomy is one of the most common surgical procedures in gynecology; however, the incidence of total hysterectomy and subtotal hysterectomy (i.e. leaving the cervix behind) varies considerably across countries, by age, and over time. As only women with an intact uterine cervix can be at risk of cervical cancer, failure to correct for hysterectomy is likely to cause an underestimation of the "true" cervical cancer incidence, which may mask the effect of prevention strategies such as screening and vaccination. Previous studies have reported a 6-59% increase in the cervical cancer incidence when removing hysterectomized women from the at-risk denominator (1) (2) (3) (4) (5) . The variability in the impact of hysterectomy on cervical cancer rates reflects the variation in hysterectomy incidence rates across countries, with the highest impact in countries with a high hysterectomy incidence such as the USA (6) . As hysterectomy incidence is cumulative with age, the impact of correcting for hysterectomy increased with age, with the corrected rate being 20-87% higher than the uncorrected rate in women aged ≥65 years (3) (4) (5) .
In Denmark, the overall incidence rate of hysterectomy has declined from 205/100 000 person-years in 1977-81 to 173/100 000 person-years in 2006-11 (7) . Moreover, the fraction of subtotal hysterectomy has varied substantially over time, peaking at 22% in the 1990s (8) . However, the incidence of hysterectomy over time differs by birth cohort, with declines most apparent in women aged <40 years (65.7% decline), and increases observed over time in women aged ≥60 years (29.6% increase).
In this population-based study we aimed to investigate the temporal and age-dependent patterns of cervical cancer incidence rates in Denmark before and after correcting for hysterectomy incidence.
Material and methods
We conducted a nationwide population-based study in Denmark where all citizens have access to comprehensive medical care at no cost, including free access to public hospitals and partial reimbursement of prescribed medications. Accurate linkage of prospectively collected data across Danish population-based registries and medical databases is possible at the individual level using the central personal registration number. The personal registration number is a unique personal identifier that is assigned to each Danish citizen at birth or upon immigration (9) . It reflects the age, sex and date of birth. Estimates reported in this study are based on the adult female population in Denmark in 2000-11 (approximately 2.6 million). Women <20 years were excluded from this study because the risk of cervical cancer in these women was considered negligible (10) . Data on the cervical cancer incidence [International Classification of Diseases, 10th revision (ICD-10) codes: DC539 and DC53*] were retrieved from the Danish National Cancer Registry. The Cancer Registry was established in 1943, aiming at capturing all incident cases of cancer in Denmark through notification from hospital departments (including departments of pathology), specialists, and autopsy reports. Additional cases are identified through the Danish National Patient Registry (DNPR), the Pathology Registry, and the Cause of Death Register. The Cancer Registry holds information on the personal registration number, diagnosis according to the International Classification of Diseases, 7th revision (ICD-7) or ICD-10, time of diagnosis, tumor location, and tumor histology according to the International Classification of Diseases for Oncology, 3rd edition. Approximately 96% of cervical cancers are histologically verified making the data of high quality (11, 12) . Based on the Systematized Nomenclature of Medicine morphology codes cervical cancer cases were classified as squamous cell carcinoma, adenocarcinoma (including adenosquamous carcinoma), or carcinoma not otherwise specified. A classification of the morphology codes is provided in the Supplementary material (Appendix S1).
We obtained information on hysterectomy incidence through the DNPR, which stores information on nonpsychiatric hospital contacts, including all in-patient admissions, to public and private hospitals in Denmark since 1977 (13) . For the purpose of this study hysterectomy incidence refers to the incidence of total hysterectomies and cervical amputations, excluding subtotal hysterectomies (i.e. leaving the cervix behind), in order for the hysterectomy incidence to reflect the proportion of women no longer at risk of cervical cancer (i.e. no intact uterine cervix). Hence, we estimated the hysterectomy incidence by searching the DNPR for surgical procedures in which the uterine cervix was removed. A complete list of ICD-8 and ICD-10 codes is provided in the Supplementary material (Appendix S2).
We calculated the cervical cancer incidence rate as the number of cervical cancers diagnosed in the study population (numerator) divided by the sum of person-years of the female population (denominator), stratified by year, age group, and histology.
We used three different approaches to derive persontime at risk (denominator): (1) not corrected for hysterectomy incidence (hereafter referred to as the uncorrected rate), (2) corrected for hysterectomy incidence based on the available data from the DNPR in 1977-2011 (hereafter referred to as known hysterectomies), and (3) further correction of person-time at risk made by incorporating the risk of hysterectomy for women ≥ 20 years, before 1977 (hereafter referred to as calculated probability of hysterectomies).
In the uncorrected approach, each woman contributed time at risk of cervical cancer beginning on 1 January 2000 or at the age of 20 years and ending at the time of cervical cancer diagnosis, death, emigration, or on 31 December 2011, whichever came first. For calculation of the hysterectomy-corrected cervical cancer incidence rate (known hysterectomies), women were excluded from the study population if they had undergone a hysterectomy between 1 January 1977 and 31 December 1999. The remaining women (i.e. those with an intact cervix) contributed time at risk of cervical cancer beginning on 1 January 2000 or at the age of 20 years and ending at the time of hysterectomy, cervical cancer diagnosis, death, emigration or on 31 December 2011, whichever came first.
As we lacked data on hysterectomies performed before 1977, we used the following approach to take into account that persons in the study population may have undergone a hysterectomy before 1977, i.e. women who were not subject to a hysterectomy during the period 1977-2011 and who were ≥20 years of age before 1977. We estimated the probability of being hysterectomized before age x [p(hyst|age≤x)] by calculating the cumulative incidence function for hysterectomies with age as the underlying time-scale and thereby also adjusted for death as competing risk (14) based on data from the period 1977-2011 (hereafter referred to as the main level case). Hence, we assumed that the age-specific probability of being hysterectomized during the period 1977-2011 was comparable to the true, but unknown, age-specific probability before 1977. Finally, the probability of not being hysterectomized before age x [1-p(hyst|age≤x)] was multiplied by the time at risk of cervical cancer for each individual woman in the group that could potentially have been hysterectomized before 1977. Women who were eligible to enter the adult female population by 1 January 2000 (i.e. women who had not had a hysterectomy during 1977-99) contributed with time at risk from this date or at the age of 20 years. End of risk was defined as the time of hysterectomy, cervical cancer diagnosis, death, emigration, or on 31 December 2011, whichever came first.
A sensitivity analysis was undertaken because of the uncertainty associated with the estimated age-specific hysterectomy probability before 1977. Hence, we modelled the cumulative incidence function using data from two alternative periods in which the hysterectomy incidence was high (1977-86, hereafter referred to as "high-level case") and low (2002-11, hereafter referred to as "lowlevel case").
Overall hysterectomy and cervical cancer incidence rates were calculated and age-standardized to the US-2000 female standard population. For comparison we used the uncorrected cervical cancer incidence rate and the hysterectomy-corrected cervical cancer incidence rate, main level case, unless otherwise indicated.
The cumulative incidence function was calculated in STATA version 12 (StataCorp LP, College Station, TX, USA). All other statistical analyses were carried out using SAS version 9.2 (SAS Institute, Cary, NC, USA). The study was approved by the Danish Data Protection Agency (record number 1-16-02-1-08).
Results
The overall incidence rate of hysterectomy declined by 22%, from 393/100 000 person-years in 1977 to 304/ 100 000 person-years in 2011 (data not shown). The largest decline was observed in women aged 20-39 years, where the hysterectomy incidence rate declined by 65.7% from 271/100 000 person-years in 1977 to 93/100 000 person-years in 2011, whereas the rate declined by 29% in women aged 40-59 years, from 693/100 000 personyears to 492/100 000 person-years ( Figure 1 ). This decline mainly occurred during 1977-95, after which the incidence tended to level out. Conversely, the hysterectomy incidence rate increased over time in women aged ≥ 60 years, from 253/100 000 person years in 1977 to 328/ 100 000 person years in 2011, equivalent to a 29.6% increase. The cumulative risk of having had a hysterectomy at age 85 years was 15.0%, 17.4%, and 20.5% using the low-level, main-level, and high-level approaches, respectively (see Supplementary material, Figure S1 ).
During the period 2000-11, the age-standardized uncorrected cervical cancer incidence rate was 17.8 per 100 000 person-years (95% CI 17.3-18.3) among women ≥20 years. After correcting for hysterectomy incidence this rate increased by 8.4% to 19.3 per 100 000 personyears (95% CI 18.8-19.9) (see Supplementary material, Table S1 ). Using alternative methods of calculation, the hysterectomy-corrected cervical cancer incidence rate was 19.0 per 100 000 person-years (95% CI 18.4-19.5) (known hysterectomies), 19.2 per 100 000 person-years (95% CI 18.7-19.8) (low-level case) and 19.5 per 100 000 person-years (95% CI 18.9-20.0) (high-level case) (see Supplementary material, Table S1 ). The age-standardized incidence rate of squamous cell carcinoma increased from 12.8 per 100 000 person-years (95% CI 12.4-13.2) to 13.9 per 100 000 person-years (95% CI 13.4-14.4) after correcting for hysterectomy, whereas the incidence of adenocarcinoma increased slightly from 3.9 per 100 000 person-years (95% CI 3.7-4.2) to 4.2 person-years (95% CI 4.0-4.5).
The highest uncorrected age-specific incidence rate of cervical cancer was observed in women aged 35-39 years (24.4/100 000 person-years); however, a second peak was seen in women aged 75-79 years (24.2/100 000 personyears) (Figure 2 ). The impact of correcting for hysterectomy incidence on cervical cancer rates increased with age. Hence, a shift in peak incidence to older ages was observed (Figure 2 , see Supplementary material, Table S1 ). The highest hysterectomy-corrected cervical cancer incidence rate was observed in women aged 75-79 years (29.4/100 000 person-years), which was 21.8% higher than the corresponding uncorrected rate. The hysterectomy-corrected incidence rate of cervical cancer increased only by 0.9% to 24.7/100 000 person-years in women aged 35-39 years. The impact of correcting for hysterectomy on the age-specific cervical cancer incidence rate did not change much when using the alternative methods of calculation (see Supplementary material, Table S1 ). When stratifying by histology, the same bimodal pattern in the age-specific incidence rate was observed in squamous cell carcinoma, but not in adenocarcinoma (Figure 3) .
The overall hysterectomy-corrected incidence rate of cervical cancer fluctuated from 20.6 per 100 000 personyears in 2001 and 2005 to 17.8 per 100 000 person-years in 2008. As the overall hysterectomy incidence rate did not change during 2000-11, the age-standardized hysterectomy-corrected rate of cervical cancer did not change over time either.
In women aged 20-39 years, the hysterectomy-corrected cervical cancer incidence rate increased by 15.5% from 16.1 per 100 000 person-years in 2000 to 18.6 per 100 000 person-years in 2011 (Figure 4a ), whereas the rate declined from 22.2 per 100 000 person-years to 20.8 per 100 000 person-years in women aged 40-59 years (6.3%) (Figure 4b) . However, the rate fluctuated over time, especially in the youngest women. In women ≥60 years, the hysterectomy-corrected cervical cancer incidence rate increased by 33.7%, from 20. Over time, women aged ≥60 years had the highest hysterectomy-corrected incidence rate of squamous cell carcinoma (see Supplementary material, Figure S2a ), whereas the hysterectomy-corrected incidence rate of adenocarcinoma (see Supplementary material, Figure S2b ) was comparable among women aged 20-39 years, 40-59 years, and ≥ 60 years. However, the incidence rate of adenocarcinoma tended to increase over calendar time in women aged 20-39 years and ≥60 years.
Discussion
This large nationwide study showed that the overall cervical cancer incidence rate increased by 8.4% after correcting for hysterectomy and that the impact of correcting for hysterectomy increased by age. Correction for hysterectomy shifted the peak in cervical cancer incidence rate from women aged 35-39 years (24.4/100 000 personyears) to women aged 75-79 years (29.4/100 000 personyears). As overall hysterectomy incidence did not change much during the period 2000-11, the age-standardized cervical cancer incidence showed no temporal change. However, temporal trends in hysterectomy incidence varied by age/birth cohort, with decreasing hysterectomy incidence in women <60 years and increasing incidence over time in women ≥60 years. As a result of these patterns, the oldest age group had the highest cervical cancer incidence, with rates increasing from 2000 to 2005 and then declining again after 2006.
The 8.4% increase in cervical cancer incidence after correcting for hysterectomy corresponds well to the 6% increased incidence rate of cervical cancer reported in a recent Danish study (1) . Differences in our corrected rates vs. those in the study by Lam et al. (1) may reflect differences in methods used to estimate the probability of hysterectomy before the initiation of the DNPR (i.e. 1977). In the study by Lam et al., the authors assumed that the proportion of hysterectomized women born before 1939 was at least the same as the proportion of hysterectomized women in birth-cohorts 1939-42. However, women born in 1939-42 were aged 35-38 years in 1977 when the registry started and so could have had a hysterectomy before the initiation of DNPR. Hence, this method likely resulted in a lower probability of hysterectomy compared with our study, in which we used data on the hysterectomy incidence during 1977-2011 to estimate the hysterectomy incidence before 1977. We assumed that the probability of hysterectomy during 1977-2011 would be similar to the true, but unknown, probability of hysterectomy before 1977.
The impact of hysterectomy on the cervical cancer incidence rate was lower in our study compared with previous studies. Studies from Germany (2) and the USA (4) have reported an increase in cervical cancer incidence rate by 28% and 59%, respectively, whereas the impact of hysterectomy was lower in studies from Finland (10.5%) (5) and the UK (14.3%) (15) . The variation in the impact of correcting for hysterectomy on cancer rates across countries likely reflects the variability in hysterectomy incidence [510 per 100 000 in the USA (16) vs. 295/100 000 in Germany (17) ]. Hence, the differences in hysterectomy incidence between countries appear to be an important contributing factor to differences in uncorrected cervical cancer incidence rates (6) . For example, without hysterectomy correction, the cervical cancer incidence in Denmark appears to be nearly 50% higher than in the USA (17.3/100 000 person-years vs. 11.7/100 000 person-years, respectively). After correcting for hysterectomy, rates are more comparable between the two countries [19. 3/100 000 person-years in Denmark vs. 18.6/100 000 person-years in the USA (4)], as would be expected in countries with comparable cervical cancer screening coverage. This example highlights the importance of hysterectomy correction to allow meaningful comparison of cervical cancer incidence rates across countries.
In our study the overall hysterectomy-corrected cervical cancer incidence remained stable over time, which is in agreement with a recent Danish study, which did not correct for hysterectomy (18) . However, some interesting differences occurred when stratifying by age. In women aged ≥ 60 years, the hysterectomy-corrected cervical cancer incidence increased from 20.5 per 100 000 person-years in 2000 to 27.4 per 100 000 person-years in 2005 and then dropped to 19.6 per 100 000 person-years in 2011. We cannot explain the increase in cervical cancer incidence, but it could reflect a generational change in risk behavior leading to higher human papillomavirus prevalence in younger birth cohorts (i.e. more sex partners and younger age at sexual debut) (19) (20) (21) . The decline may be explained by several factors, such as an increase in the hysterectomy incidence in recent years among women ≥ 60 years, more focus on cervical cancer screening, and an increase in screening coverage over time, reaching 100% in 2007 (22, 23) . Also, the decline might, to some extent, be attributed to the changes in the national screening guidelines in 2007 where cessation of cervical cancer screening was extended from 59 years to 64 years (23) .
Screening for cervical cancer was implemented in Denmark in the 1960s and currently women aged 23-64 years are recommended regular screening every 3 (women aged 23-49 years) to 5 (women aged 50-64 years) years. The fact that the cervical cancer incidence rate over time was highest in women who are about to exit screening or have been exited is worrisome. From previous studies we know that older women are more likely to be diagnosed with advanced stage disease (24, 25) and that their mortality is high (23, 25) . Although this may reflect a higher proportion of unscreened or inadequately screened older women, recent studies from the USA (26, 27) and UK (28) have indicated that screening beyond the age of 65 years may decrease the incidence as well as the mortality of cervical cancer significantly. The British study specifically estimated that 50% of the cervical cancers occurring in women >65 years could be prevented if cessation of cervical cancer screening was postponed from 65 years to 75 years (28) . As the peak incidence in cervical cancer observed in older women is merely due to a high incidence of squamous cell carcinoma, offering screening for cervical cancer to older women may lead to a reduction in the burden of cervical cancer at older ages, although we acknowledge the reduced sensitivity of cervical cytology in older women.
A limitation of this study was that we were unable to retrieve data on hysterectomies performed before 1977. However, as the oldest women in 2000-11 may have had a hysterectomy before 1977, we found it paramount to somehow estimate the hysterectomy incidence before 1977. Strengths of this study include adjusting for death as competing risk when estimating the cumulative incidence of hysterectomy, which probably led to a more accurate estimate. Second, because trends in hysterectomy incidence may have been lower or higher in the time periods before DNPR, we undertook a sensitivity analysis in which the cumulative incidence was varied based on the assumption that the historic cumulative incidence before 1977 would mimic known incidence rates in recent time; i.e. from 1977 to 1986 (high-level case) and 2002 to 2011 (low-level case), respectively. We found that the overall hysterectomy-corrected cervical cancer incidence rate was rather insensitive to changes in the cumulative hysterectomy incidence. This may indicate that our correction method is generally robust, although differences may be underestimated, particularly in the older age group. Third, we were able to differentiate between subtotal and total hysterectomies, a differentiation that is particularly important in Denmark given the high rate of subtotal hysterectomies in the 1990s (i.e. 22%) (8).
Conclusion
Correcting for hysterectomy incidence when calculating the cervical cancer incidence may, at least partly, level out the observed differences in the uncorrected cervical cancer rates across countries with effective screening programs. Given that Danish women aged 75-79 years had the highest corrected cervical cancer incidence of all ages (29.4/100 000) and some evidence of a reduction in the peak mode of cervical cancer incidence in women aged ≥ 60 years following an increase in age to exit screening from 59 to 64 years, consideration of further increases in the age to exit screening may be warranted.
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